Fulcrum Therapeutics (FULC) Receivables - Net (2020 - 2022)

Fulcrum Therapeutics (FULC) has 3 years of Receivables - Net data on file, last reported at $13000.0 in Q3 2022.

• On a quarterly basis, Receivables - Net changed N/A year-over-year to $13000.0 in Q3 2022; TTM through Sep 2022 was $13000.0, a N/A change from a year earlier, with the FY2021 full-year figure at $2.5 million, up 25.0% from the prior year.
• Receivables - Net for Q3 2022 stood at $13000.0, down from $357000.0 in the prior quarter.
• Over the last five years, Receivables - Net for FULC reached as high as $2.5 million in Q4 2021 and fell as low as $13000.0 in Q3 2022.
• Historically, Receivables - Net has averaged $1.2 million across 3 years, with a median of $1.2 million in 2020.
• On a YoY basis, Receivables - Net climbed as much as 25.0% in 2021 and fell as far as 25.0% in 2021.
• Year by year, Receivables - Net stood at $2.0 million in 2020, then increased by 25.0% to $2.5 million in 2021, then slumped by 99.48% to $13000.0 in 2022.
• Per Business Quant data, the three most recent Receivables - Net figures were $13000.0 in Q3 2022, $357000.0 in Q2 2022, and $2.5 million in Q4 2021.